Hytracin Brand names, Hytracin Analogs
Hytracin Brand Names Mixture
Hytracin fda sheet
Hytracin msds (material safety sheet)
Hytracin Synthesis Reference
M. Winn et al., U.S. Pat. 4,026,894 (1977)
Hytracin Molecular Weight
Hytracin Melting Point
Hytracin H2O Solubility
Hytracin Dosage Forms
For the treatment of symptomatic benign prostatic hyperplasia (BPH) and also for hypertension.
Terazosin, classified as a quinazoline, is similar to doxazosin and prazosin. As an alpha-adrenergic blocking agent, terazosin is used to treat hypertension and benign prostatic hypertrophy (BPH). Terazosin produces vasodilation and reduces peripheral resistance but in general has slight effect on cardiac output. Antihypertensive effect with chronic dosing is usually not accompanied by reflex tachycardia.
Essentially completely absorbed in man (90% bioavailability).
Hytracin side effects and Toxicity
LD50=259.3mg/kg (i.v. in mice)
Hytracin Patient Information
Hytracin Organisms Affected
Humans and other mammals